Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Institut de Cancérologie Lucien Neuwirth (ICLN) is a private, non-profit comprehensive cancer center located in Saint-Priest-en-Jarez, France, and is a member of the prestigious Unicancer network. It serves as a regional leader in oncology, providing integrated care that includes medical oncology, radiotherapy, and clinical research for patients in the Loire department. The institute is equipped with advanced technical platforms for radiation therapy, including VMAT and stereotactic techniques, as well as specialized units for hematology and supportive care. ICLN is heavily involved in clinical research, participating in numerous international phase 1, 2, and 3 trials to offer patients access to the latest therapeutic innovations. Its multidisciplinary approach combines medical expertise with teaching and research through partnerships with the University Hospital of Saint-Étienne.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institut de Cancérologie Lucien Neuwirth.